Breadcrumb Trail Links
The researchers found no evidence that those given THC fared better than the placebo group.
Author of the article:
The fresh toast Photo by Bumblee_Dee / iStock / Getty Images Plus• •
Cannabis advocates have said for the past decade that marijuana is more if not all of the other drugs are more effective in taming post-traumatic stress disorder (PTSD). However, a long-awaited study approved by the Food and Drug Administration aimed at learning more about the effectiveness of cannabis for PTSD shows that this may not be the case.
Researchers found that while weeds are a safe and commonly used treatment option for those affected, they are not as effective as originally thought.
Before anyone sit back, keep in mind that Dr. Sue Sisley of the Scottsdale Research Institute oversaw the study. Dr. Sisley has long been a proponent of medical marijuana and works diligently to find answers to whether or not cannabis can help military veterans with PTSD. She fought for Uncle Sam’s permission to start the research for nearly a decade, and her team spent three years searching for answers.
Study shows cannabis temporarily relieves PTSD symptoms
The Battle Brothers Foundation is working with a medical records company to study how cannabis can fight PTSD
Retired Admiral campaigns for Australia to rethink psychedelics
But all of these efforts seem to have produced nondescript results.
The $ 2 million study, funded by the Colorado Department of Public Health and Environment (CDPHE) to the Multidisciplinary Association of Psychedelic Studies (MAPS), included 76 veterans with PTSD. Some participants received a mixture of cannabis with THC levels between eight and 12 percent, while others received a placebo.
In the end, the researchers found no evidence that those given THC fared better than the placebo group. In fact, participants who received the placebo said they actually received the original.
“The study found no significant difference in the change in PTSD symptom severity between active cannabis concentrations and placebo by the end of stage 1,” the study authors wrote. “All three active concentrations of smoked cannabis were generally well tolerated.”
Photo by Getty Images
The researchers suspect that the quality of cannabis has something to do with the lackluster results.
All of the marijuana grown for the federal government comes from the University of Mississippi. It has long been argued that the quality and effectiveness of this product for research purposes is below average, especially given the higher standard for weed sales in rule of law.
“It took this study seven years to get approved and three years to run at a cost of $ 2.2 million. The difference between individual reports and these results may be in the quality of the marijuana, “said Rick Doblin, Ph.D., Executive Director of MAPS.” This underscores the need for more well-controlled clinical trials that more accurately represent the marijuana products currently available . High quality cannabis flowers that are eligible for FDA approval are currently not available domestically due to production restrictions by the U.S. Department of Justice and the Drug Enforcement Administration and must be imported. “
This is the path that researchers will go next.
Dr. Sisley insists that her team will move on and try to do more extensive cannabis studies. “Despite the absurd restrictions that federal criminals have placed on research for more than 50 years, we are fully focused on starting further Phase 2 studies of imported cannabis from tested, more potent, fresher buds that provide a valid comparison for Millions of veterans and veterans supply others with PTSD who are looking for new options, “she said in a statement.
We apologize, but this video could not be loaded.
The FreshToast.com, a US lifestyle website that provides lifestyle content and, through its partnership with 600,000 doctors, distributes medical marijuana information to The GrowthOp through Skipta.
Subscribe to Weekend Dispensary, a new weekly newsletter from The GrowthOp.